{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:18:22Z","timestamp":1774433902825,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.lungcan.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T13:02:13Z","timestamp":1497704533000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study"],"prefix":"10.1016","volume":"111","author":[{"given":"Elisa","family":"Gobbini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Gregorc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vieri","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Buffoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Delmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tindara","family":"Franchina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Migliorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Cortinovis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Pisconti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Bordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Catino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaristo","family":"Maiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Arizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2017.06.009_bib0005","unstructured":"I numeri del cancro in Italia\u20132016, (n.d.). http:\/\/www.registri-tumori.it\/cms\/it\/node\/4572 (Accessed 20 April 2017)."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0010","unstructured":"Cancer Statistics Review, 1975\u20132014\u2013SEER Statistics, (n.d.). https:\/\/seer.cancer.gov\/csr\/1975_2014\/ (Accessed 20 April 2017)."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0015","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(16)31473-8","article-title":"New and emerging targeted treatments in advanced non-small-cell lung cancer","volume":"388","author":"Hirsch","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0035","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0040","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"J\u00e4nne","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0045","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1200\/jco.2015.33.15_suppl.8059","article-title":"ASCEND-2: a single-arm, open-label, multicenter phase II study of ceritinib in adult patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ)","volume":"33","author":"Mok","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1470-2045(15)00488-X","article-title":"Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial","volume":"17","author":"Shaw","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/annonc\/mdu145","article-title":"Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer","volume":"25","author":"Kerr","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0060","unstructured":"Linee Guida 2016, Aiom. (n.d.). http:\/\/www.aiom.it\/professionisti\/documenti-scientifici\/lineeguida (Accessed 20 April 2017)."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0065","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations","volume":"373","author":"Hyman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0075","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1200\/jco.2013.31.15_suppl.8009","article-title":"Interim results of phase II study BRF113928 of dabrafenib in BRAF V600E mutation\u2013positive non-small cell lung cancer (NSCLC) patients","volume":"31","author":"Planchard","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0080","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1200\/JCO.2012.45.6095","article-title":"Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives","volume":"31","author":"Mazi\u00e8res","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0085","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/annonc\/mdv186","article-title":"Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors","volume":"26","author":"Kris","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0090","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1158\/1078-0432.CCR-11-2201","article-title":"Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups","volume":"18","author":"Andre","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrclinonc.2012.42","article-title":"Tumour molecular profiling for deciding therapy-the French initiative","volume":"9","author":"Nowak","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/EdBook_AM.2013.33.332","article-title":"Europe does it better: molecular testing across a national health care system-the French example","author":"Nowak","year":"2013","journal-title":"Am. Soc. Clin. Oncol. Educ. Book Am. Soc. Clin. Oncol. Meet."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0105","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2017.06.009_bib0110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0115","unstructured":"Linee Guida 2013, Aiom. (n.d.). http:\/\/www.aiom.it\/professionisti\/documenti-scientifici\/linee%2dguida\/1,413,1 (Accessed 20 April 2017)."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0120","unstructured":"Linee Guida 2015, Aiom. (n.d.). http:\/\/www.aiom.it\/professionisti\/documenti-scientifici\/lineeguida (Accessed 20 April 2017)."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0125","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","article-title":"New pathologic classification of lung cancer: relevance for clinical practice and clinical trials","volume":"31","author":"Travis","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.lungcan.2017.06.009_bib0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0140","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","volume":"387","author":"Barlesi","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0145","unstructured":"Search of: lung cancer | Recruiting | Interventional Studies | Italy | Phase 1, 2, 3, 4 \u2013 List Results \u2013 ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/results?term=lung+cancer&type=Intr&rslt=&recr=Recruiting&age_v=&gndr=&cond=&intr=&titles=&outc=&spons=&lead=&id=&state1=&cntry1=EU%3AIT&state2=&cntry2=&state3=&cntry3=&locn=&phase=0&phase=1&phase=2&phase=3&rcv_s=&rcv_e=&lup_s=&lup_e= (Accessed 28 May 2017)."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0150","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","article-title":"ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer","author":"Gainor","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0155","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/JTO.0b013e318290868f","volume":"8","author":"Lindeman","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0160","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","article-title":"Phase III randomized trial comparing three platinum-based doublets in advanced non\u2013small-cell lung cancer","volume":"20","author":"Scagliotti","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2017.06.009_bib0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12032-014-0339-3","article-title":"Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans\u2019 Affairs Central Cancer Registry (VACCR) cohort analysis","volume":"32","author":"Bhatt","year":"2015","journal-title":"Med. Oncol. Northwood Lond. Engl."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217303628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500217303628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T10:01:54Z","timestamp":1602324114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500217303628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"alternative-id":["S0169500217303628"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.06.009","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}